Screener / SEC EDGAR /CIK 0001781755 /10-K filed Feb 26, 2026, compared with Feb 25, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Financials · Insurance Brokers

Baldwin Insurance Group, Inc. BWIN

Compare with peers Embed
The 10-K against last year's

126 changes: 28 added, 13 removed, 85 reworded

10-K Feb 26, 2026 vs Feb 25, 2025

10-K 0001781755-26-000018 (Feb 26, 2026) vs 10-K 0001781755-25-000017 (Feb 25, 2025)

Every paragraph, and how much of it changed

One bar per paragraph, in the order of the 10-K. Height and colour show the share of its words not in the closest paragraph a year earlier; the tallest bars are new paragraphs.

Risk Factors

295 paragraphs · 7 new · 36 reworded · 0 gone · 10-K Feb 26, 2026 against Feb 25, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 111 · 43% changed Every version of it
When we acquire partners, we record goodwill and other intangible assets. As of December 31, 2024, 2025, we had $1.5 billion of goodwill recorded on our balance sheet, which represented 40% 39% of our total assets. Goodwill is not amortized and is subject to assessment for impairment when the facts and circumstances suggest an impairment test is necessary, but in any event, at least annually. The identification and measurement of goodwill impairment involves the estimation of the fair value of our reporting units. We compare the fair value of each reporting unit with its carrying amount to determine if there is potential impairment of goodwill. Management reviews The determinations of impairment indicators and the carrying fair value attributed are based on estimates and assumptions related to each reporting unit at least annually the amount and timing of future cash flows and future interest rates. Such estimates and assumptions could change in the future as more information becomes available, which could impact the amounts reported and disclosed. A significant and sustained decline in our stock price and market capitalization, a significant decline in our expected future cash flows, a significant adverse change in the business climate, or slower growth rates could result in the need to determine if perform an additional impairment analysis prior to the facts next annual goodwill impairment test. If we were to conclude that a future impairment of our goodwill is necessary, we would then record the appropriate charge, which could result in material charges that are adverse to our operating results and circumstances suggest that there is impairment. financial position.
Paragraph 99 · 19% changed Every version of it
Strategic acquisitions to complement and further expand our business, which we refer to as partnerships, have been an important part of our competitive strategy. The acquisition landscape is competitive and accordingly competitive. However, we do not expect that partnerships will be as important to our growth in 2025, although we will remain active and opportunistic in pursuing potential transactions. Our ability to identify and complete acquisitions, or if we are inefficient or unsuccessful at integrating any partner into our operations, may impact our ability to achieve our planned rates of growth or improve our market share, profitability or competitive position in specific markets or services. The process of integrating a partner has created, and will continue to create, operating difficulties. The risks we face include:
Paragraph 41 · 17% changed Every version of it
As of December 31, 2024, 2025, we had total consolidated debt outstanding of approximately $1.44 $1.7 billion, collateralized by substantially all of Baldwin Holdings' assets, including a pledge of all equity securities Baldwin Holdings holds in each of its subsidiaries. During the year ended December 31, 2024, 2025, we had debt servicing costs of $583.5 $279.1 million, inclusive of $453.8 $163.2 million in principal repayments and $111.4 $115.3 million of interest payments. On January 2, 2026, we incurred an additional $600.0 million of incremental term B loans under the JPM Credit Agreement, increasing our indebtedness and related debt service obligations.
Paragraph 109 · 15% changed Every version of it
Our partnership strategy is also affected by our ability to secure additional debt or equity financing in the future to fund acquisitions. We may not be able to obtain such additional financing or, if available, it may not be in amounts and on terms acceptable to us. To the extent we finance acquisitions or related deferred or contingent consideration through additional indebtedness or the issuance of equity, our interest expense may increase and/or our stockholders may experience dilution. We cannot predict or guarantee that we will successfully identify suitable acquisition candidates, consummate any partnership or integrate any partner. partner, including CAC Group. Any failure to do so could have an adverse impact on our business, results of operations and financial condition.
Paragraph 20 · 15% changed Every version of it
•We are exposed to risk of impairment of goodwill. An impairment of goodwill could have a material adverse effect on our financial condition and results of operations.
Paragraph 110 · 15% changed Every version of it
We are exposed to risk of impairment of goodwill. An impairment of goodwill could have a material adverse effect on our financial condition and results of operations.
Paragraph 38 · 12% changed Every version of it
As of December 31, 2024, 2025, our cash and cash equivalents were $148.1 $123.7 million and we had $588.0 $477.0 million of available borrowing capacity on the Revolving Facility under the 2024 JPM Credit Agreement. We will continue to expend substantial cash resources for the foreseeable future for servicing our debt obligations and future earnout payment liabilities. Following the successful refinancing of our Term Loan B on January 10, 2025, 2, 2026, borrowings under our 2024 JPM Credit Agreement include $935.8 million $1.604 billion under the Term Loan B bearing interest of 7.30%, 6.25%, maturing May 2031. There were no As of December 31, 2025, outstanding borrowings on the Revolving Facility, which has an expiration date of Facility were $107.0 million, bearing interest at 6.39% and maturing May 2029, however and we had unused letters of credit issued under the Revolving Facility of $12.0 $16.0 million. On May 24, 2024, As of December 31, 2025, we issued had $600.0 million in aggregate principal amount of the 7.125% Senior Secured Notes due May 2031. In connection with certain prior partnerships and acquisitions of select books of business, we are required to pay contingent earnouts. Based on estimates of the partners’ future performance using financial projections for the earnout period, the aggregate estimated contingent earnout liabilities included on our consolidated balance sheet at December 31, 2024 2025 was $145.6 $23.3 million, of which $4.7 $9.2 million must be settled in cash and the remaining $140.8 $14.1 million can be settled in cash or stock at our option. The undiscounted estimated contingent earnout obligation at December 31, 2024 2025 was $185.2 $26.6 million, of which $5.0 $9.2 million must be settled in cash and the remaining $180.2 $17.4 million can be settled in cash or stock at our option. The maximum estimated exposure to the contingent earnout liabilities was $268.8 $50.0 million at December 31, 2024. 2025. In addition, in connection with our partnership with CAC Group, a nationally recognized specialty and middle-market insurance brokerage firm on January 1, 2026 (the CAC Group Transaction), we are required to pay a deferred cash consideration payment of $70.0 million in 2030 and a contingent earnout of up to $250.0 million. On January 2, 2026, Baldwin Holdings entered into an amendment to the JPM Credit Agreement that provided for $600.0 million of incremental term B loans, the proceeds of which Baldwin Holdings has used, and intends to use, to finance or refinance the cash consideration paid in connection with the CAC Group Transaction and for other permitted purposes, and which has increased our overall leverage and debt service requirements. There is no assurance that we will have sufficient cash flows from operating activities, cash on hand and available capital sources to service any indebtedness or pay contingent earnout liabilities when due, or finance other working capital needs, and failure to do so may result in a material adverse effect on our business, operations, and financial condition. Refer to Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources—Contractual Obligations and Commitments for further discussion of our debt obligations and contingent earnout liabilities.
Paragraph 122 · 12% changed Every version of it
In the future, it may become necessary for us to offer insurance products from a reduced number of insurance and reinsurance company partners or to derive a greater portion of our commissions and fees from a more concentrated number of insurance and reinsurance company partners as our business and the insurance industry evolve. The number of referral and other trading partners we do business with could also be reduced in the future. Should our dependence on a smaller number of insurance and reinsurance company partners, referral partners or other trading partners increase, whether as a result of the termination of insurance and reinsurance company partner, referral partner or other trading partner relationships, the consolidation of insurance and reinsurance company partner consolidation partners, referral partners or other trading partners, or otherwise, we may become more vulnerable to adverse changes in our relationships with our insurance and reinsurance company partners, these counterparties, particularly in states where we offer insurance products from a relatively small number of insurance and reinsurance company partners or partners, where a small number of insurance companies dominate the market. market, or where a significant portion of our commission and fees is directly or indirectly derived from our relationships with referral partners or other trading partners. The termination, amendment or consolidation of our relationship with our insurance and reinsurance company partners, referral partners or other trading partners could harm our business, financial condition and results of operations.

MD&A

158 paragraphs · 21 new · 70 reworded · 13 gone · 10-K Feb 26, 2026 against Feb 25, 2025
New paragraph Reworded (5% of its words or more) Same or nearly
Paragraph 37 · 50% changed
Other operating expenses in MIS assets increased $3.9 $34.4 million year over year, driven by higher technology-related costs to investments in third party businesses that support the growth of the our business, higher deferred commission expense related to new business growth and capitalization of $1.1 million, licenses and taxes of $0.7 million, advertising and marketing of $0.7 million, and travel and entertainment of $0.3 million. implementation costs related to new technology platforms.
Paragraph 5 · 49% changed
Operating expenses for the year ended December 31, 2024 2025 were $1.3 $1.4 billion, an increase of $67.3 $102.6 million, or 5%, 8%, year over year. The increase in operating expenses was primarily attributable to commissions, employee compensation and benefits, resulting in part from the correlation of compensation to our revenue growth, and as a result of investing in our future driven by higher other operating expenses, including increased technology outlay as we continue to launch new products invest in automation and efficiency and higher incurred losses and loss adjustment expense related to our MSI product suite newly established Captive business, as well as higher colleague compensation and expand benefits and outside commissions, largely reflecting the correlation between compensation and revenue growth, and increased amortization expense associated with our business. This increase was offset in part by a decrease in the change in fair value of contingent consideration, which was primarily impacted by a gain recognized in connection with the reclassification of colleague earnout incentives into compensation expense. partnership activity.
Paragraph 101 · 49% changed
Outside commissions for Corporate and Other records results from the elimination of intercompany revenue commission expense from the operating groups. During 2024, UCTS recorded commissions revenue shared with other operating groups of $77.6 million and MIS recorded commissions revenue shared within the same operating group of $1.6 million.
Paragraph 100 · 48% changed
Commissions, employee Colleague compensation and benefits expense for MIS in Corporate and Other increased $27.9 million, or 19%, $7.3 million year over year, primarily due to outside commissions, which increased $15.3 million, or 25%, relating to growth in our Westwood and legacy Mainstreet businesses. Other increases included colleague compensation of $7.6 million, inside advisor commissions of $3.5 million and benefits and other of $2.2 million, which were driven by continued investments in headcount to support our growth, coupled with an increase in colleague compensation allocated in IT to MIS that was previously recognized in Corporate support our continued growth and Other. technology investments, as well as elevated health plan costs.
Paragraph 77 · 48% changed
Commissions, employee Colleague compensation and benefits expense for IAS increased $87.2 decreased $13.3 million, or 19%, 3%, year over year primarily due to an increase a decrease in colleague earnout incentives of $41.0 million resulting from settlement activity in 2025, partially offset by increases in colleague compensation of $36.4 million, driven by continued investments in headcount to support our growth, coupled with an increase in colleague compensation allocated to IAS that was previously recognized in Corporate $14.6 million and Other. IAS commissions, employee compensation and benefits expense for 2024 also included an increase related to colleague earnout incentives of $30.8 million for contingent earnout liabilities that were reclassified, at the partner's option, to an earnout incentive bonus payable to colleagues. In addition, inside advisor commissions increased $14.5 million, or 9%, in line with the growth in IAS’ core commissions of $7.6 million related to our growth, and fees. benefits and other of $5.2 million related to elevated health plan costs.
Paragraph 88 · 47% changed
Corporate and Other amortization Amortization expense for UCTS increased $1.0 $6.2 million year over year due to year, driven by an increase in capitalized software development costs. and our 2025 partnership activity.
Paragraph 24 · 46% changed
UCTS Outside commissions and fees increased $66.4 $9.9 million, or 16%, 4%, year over year to $468.9 year. After excluding outside commissions of $3.0 million earned by the Wholesale Business during 2024 for which there was no comparable expense in 2025, outside commissions increased $12.9 million, due to organic growth in core or 5%. Outside commissions and fees. Growth in our increased at a lower rate than core commissions and fees was driven by primarily due to continued outperformance in scaling of our multi-family business (accounting for $35.7 million of UCTS business, product mix shift and contributions from the increase in core commissions and fees), momentum in our homeowners product (accounting for $36.8 million of the increase in core commissions and fees) and commercial umbrella product (accounting for $9.9 million of the increase in core commissions and fees), and growing contribution from our reinsurance brokerage business and commercial property program. This growth was offset in part by core commissions and fees of $26.8 million derived from our Wholesale Business between March and December of 2023, for which there were no comparable revenues earned in 2024. Core commissions and fees growth, excluding such revenue related to the Wholesale Business between March and December of 2023, was 30%. Capacity Solutions group (which generally does not have significant outside commissions).
Paragraph 102 · 44% changed
Other operating expenses in Corporate and Other amortization expense increased $1.0 $3.5 million year over year primarily due to capitalized software development costs. higher professional fees of $3.8 million due to partnership activity.

A paragraph is matched with the one last year that shares the most of its words; under half in common makes it new. The paragraphs shown are the 8 reworded the most in each section.

The paragraph that changed most in each section

The redline

Marked against last year's 10-K: cut words struck through, new words highlighted.

MD&A422 words changed in this paragraph; it is 65% similar to last year's version.
Description Judgments and Uncertainties Effect if Actual Results Differ from Assumptions Valuation of Contingent Consideration Substantially all of our partnerships and certain acquisitions of select books of business that do not constitute a complete business enterprise include contingent consideration arrangements, which are based on the acquired company achieving thresholds related to future revenues, total insured value EBITDA or number of rented units. retention rates. The structure of these contingent earnout arrangements can reduce the risk of overpaying for acquisitions if the projected financial results are not achieved. The fair value of the contingent consideration arrangements is estimated by simulating the metrics corresponding to a payment using a Monte Carlo Simulation approach and discounting the expected future contingent payments to present value. The key assumptions used in our valuation were: (i) forecast of revenue, total insured value EBITDA or number of rented units, retention rates, (ii) the volatility associated with the revenues, total insured value EBITDA or number of rented units, retention rates, (iii) risk-adjusted discount rate applied to forecasted revenues, total insured value EBITDA or number of rented units, retention rates, and (iv) the credit-adjusted discount rate related to the payment of the contingent consideration. We review and re-assess During the estimated fair value of contingent consideration on a quarterly basis, and the updated fair value could be materially different from the initial estimates or prior quarterly amounts; however, the fair value of contingent consideration liabilities becomes less uncertain as partners approach their respective measurement dates. Any last three years, we have not made any changes in the estimated fair accounting methodology used to value of contingent consideration and adjustments to the estimated fair value related to unobservable inputs will be recognized within change in fair value of contingent consideration in the consolidated statements of comprehensive loss. We recognized a $4.9 million benefit related to the change in fair value of contingent consideration in 2024. consideration. The fair values of these contingent consideration arrangements are included as part of the purchase price of the acquired companies on their respective acquisition dates. For each transaction, we estimate the fair value of contingent earnout payments as part of the initial purchase price and record the estimated fair value of contingent consideration as a liability on the consolidated balance sheets. The fair values of the earnout arrangements are estimated by discounting the expected future contingent payments to present value using a variation of the income approach, specifically using a Monte Carlo Simulation approach. We have 9 five partners with a corresponding contingent consideration liability still outstanding at December 31, 2024. At December 31, 2024, we recorded $145.6 million of contingent consideration liabilities related to the 9 contingent consideration arrangements still outstanding and the total potential maximum of the remaining contingent consideration payments is $268.8 million. If all remaining revenue, insured value, and rented units targets were to be achieved, our partners would be entitled to payments of up to $258.8 million in calendar year 2025 for achieving targets through September 30, 2025; and $10.0 million in calendar year 2026 for achieving targets through September 30, 2026. If the actual achievement of contingent consideration payments in 2025 through 2026 was at the maximum target amounts, we would record an additional $123.2 million of expense over the next two years. 2025. These estimates are influenced by many factors, including historical financial information, guideline public company data, and management's expectations for future revenue revenue, EBITDA or retention rates of the acquired businesses, total insured value and number of rented units, as well as market conditions, economic conditions and the company’s performance. Changes in these inputs could have a significant impact on the fair value of the contingent consideration liability. We review and re-assess the estimated fair value of contingent consideration on a quarterly basis, and the updated fair value could be materially different from the initial estimates or prior quarterly amounts; however, the fair value of contingent consideration liabilities becomes less uncertain as partners approach their respective measurement dates. Any changes in the estimated fair value of contingent consideration and adjustments to the estimated fair value related to unobservable inputs will be recognized within change in fair value of contingent consideration in the consolidated statements of comprehensive loss. We recognized a $5.6 million expense related to the change in fair value of contingent consideration in 2025. At December 31, 2025, we recorded $23.3 million of contingent consideration liabilities related to the five contingent consideration arrangements still outstanding and the total potential maximum of the remaining contingent consideration payments is $50.0 million. If all remaining revenue, EBITDA and retention rate targets were to be achieved, our partners would be entitled to payments of up to $39.0 million in calendar year 2026 for achieving targets through September 30, 2026; and $5.5 million in calendar year 2027 for achieving targets through September 30, 2027; and $5.5 million in calendar year 2028 for achieving targets through September 30, 2028. If the actual achievement of contingent consideration payments in 2026 through 2028 was at the maximum target amounts, we would record an additional $26.7 million of expense over the next three years. This analysis does not take into account the assumed obligation from Hippo's Homebuilder Distribution Network, which does not have a maximum.

Source: Item 7, 10-K 0001781755-26-000018 vs Item 7, 10-K 0001781755-25-000017

Risk Factors177 words changed in this paragraph; it is 49% similar to last year's version.
When we acquire partners, we record goodwill and other intangible assets. As of December 31, 2024, 2025, we had $1.5 billion of goodwill recorded on our balance sheet, which represented 40% 39% of our total assets. Goodwill is not amortized and is subject to assessment for impairment when the facts and circumstances suggest an impairment test is necessary, but in any event, at least annually. The identification and measurement of goodwill impairment involves the estimation of the fair value of our reporting units. We compare the fair value of each reporting unit with its carrying amount to determine if there is potential impairment of goodwill. Management reviews The determinations of impairment indicators and the carrying fair value attributed are based on estimates and assumptions related to each reporting unit at least annually the amount and timing of future cash flows and future interest rates. Such estimates and assumptions could change in the future as more information becomes available, which could impact the amounts reported and disclosed. A significant and sustained decline in our stock price and market capitalization, a significant decline in our expected future cash flows, a significant adverse change in the business climate, or slower growth rates could result in the need to determine if perform an additional impairment analysis prior to the facts next annual goodwill impairment test. If we were to conclude that a future impairment of our goodwill is necessary, we would then record the appropriate charge, which could result in material charges that are adverse to our operating results and circumstances suggest that there is impairment. financial position.

Source: Item 1A, 10-K 0001781755-26-000018 vs Item 1A, 10-K 0001781755-25-000017

Accounting Policies109 words changed in this paragraph; it is 53% similar to last year's version.
The Company utilizes derivative financial instruments, consisting of including, from time to time, interest rate caps, caps and swaps, to manage the Company’s interest rate exposure. The Company does not use derivative instruments for trading or speculative purposes. Derivative instruments are recognized as assets or liabilities at fair value on the consolidated balance sheets. The Company Company's interest rate swap has not been designated these derivatives as hedging instruments for accounting purposes a cash flow hedge under ASC Topic 815, Derivatives and Hedging (“Topic 815”) and, accordingly, the changes in fair value of these derivatives are recognized in earnings. Cash payments and receipts under the derivative instruments are recorded in accumulated other comprehensive income, which is a component of stockholders' equity on the consolidated balance sheets. The net cash settlements of the interest rate swap are classified within cash flows from financing operating activities in the accompanying consolidated statements of cash flows. The Company does not use derivative instruments for trading or speculative purposes. Company’s hedging program extends through September 2028.

Source: Item 8, Note 2 – Significant Accounting Policies, 10-K 0001781755-26-000018 vs Item 8, Note 2 – Significant Accounting Policies, 10-K 0001781755-25-000017

Legal Proceedings20 words changed in this paragraph; it is 97% similar to last year's version.
On February 8, 2023, Ruby Wagner, a putative Class A stockholder of the Company, filed a class action lawsuit (the “Lawsuit”), on behalf of herself and other similarly situated stockholders in the Delaware Court of Chancery against the Company seeking declaratory judgment that certain provisions of the 2019 Stockholders Agreement between the Company and the Pre-IPO LLC Members are invalid and unenforceable as a matter of Delaware law. On May 28, 2024, the Court of Chancery issued an opinion (the “Chancery Court Opinion”) that certain provisions of the 2019 Stockholders Agreement granting approval rights related to amending the Company’s certificate of incorporation and making significant decisions relating to the Company’s senior management, are facially invalid, void, and unenforceable under Delaware law. An implementing order, presently in effect, was entered on June 20, 2024. The Chancery Court Opinion also held that a severability provision in the 2019 Stockholders Agreement allows the Pre-IPO LLC Members to demand a “suitable and equitable substitute” for the approval rights that were deemed invalid, such as the issuance of a so-called golden share of preferred stock in the Company. Following the Chancery Court Opinion, a counterparty to the 2019 Stockholders Agreement requested the issuance of such golden share. An independent committee of our board of directors, advised by independent counsel, determined that entering into a contractual agreement containing substantially the same rights as those contained in the 2019 Stockholders Agreement, as authorized by a newly-enacted provision of Delaware law, rather than issuance of a golden share, would be in the best interests of the Company and our stockholders and, following negotiation, the Company entered into the 2024 Stockholders Agreement on October 30, 2024. On January 22, 2025, the Court of Chancery granted plaintiff an award of attorneys' fees and expenses in the amount of $2.4 million (the "Fee Award"). The On February 21, 2025, the Company appealed filed an appeal from the Chancery Court Opinion and the Fee Award on February 21, 2025. with the Delaware Supreme Court. Due to the Company's Company’s appeal, management has estimated the potential range of loss from the ultimate disposition of this matter to be between $0, if the appeal is successful, and $2.4 million, if the Fee Award is upheld, a significant portion of which may be covered by insurance.

Source: Item 3, via Note 22 – Commitments and Contingencies, 10-K 0001781755-26-000018 vs Item 3, via Note 20 – Commitments and Contingencies, 10-K 0001781755-25-000017

Sentences and paragraphs added, removed or reworded

Every change, by type

Sentences and paragraphs of BWIN's Risk Factors and MD&A, 10-K Feb 26, 2026 against 10-K Feb 25, 2025. Each links to the text at sec.gov.

Quiet changes are sentences kept from last year with one to four words changed, at least one of them a hedge, a modal or a qualifier (may, could, will, not, significant, material…). A year or date rolling forward is not counted.

The full word list

adverse, adversely, all, although, anticipate, anticipates, any, approximately, believe, believes, can, cannot, certain, could, expect, expects, generally, however, if, intend, intends, largely, likely, many, material, materially, may, might, most, must, never, no, not, possible, primarily, probable, should, significant, significantly, some, substantial, substantially, unlikely, will, would

AddedRisk Factors
We utilize artificial intelligence, machine learning, and similar tools and technologies that collect, aggregate, analyze or generate data or other materials or content (collectively, “AI”) in connection with our business. There are significant risks involved in utilizing AI and no assurance can be provided that our use of such AI will enhance our products or services or produce the intended results. For example, AI algorithms may be flawed, insufficient, of poor quality, reflect unwanted forms of bias, or contain other errors or inadequacies, any of which may not be easily detectable; AI has been known to produce false or “hallucinatory” inferences or outputs; AI can present ethical issues and may subject us to new or heightened legal, regulatory, ethical, or other challenges; and inappropriate or controversial data practices by developers and end-users, or other factors adversely affecting public opinion of AI, could impair the acceptance of AI solutions, including those incorporated in our products and services. If the AI tools that we use are deficient, inaccurate or controversial, we could incur operational inefficiencies, competitive harm, legal liability, brand or reputation harm, or other adverse impacts on our business and financial results. If we do not have sufficient rights to use the data or other material or content on which the AI tools we use rely, or the output of such AI tools, we also may incur liability through the violation of applicable laws and regulations, third-party intellectual property, privacy or other rights, or contracts to which we are a party.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedRisk Factors
In addition, regulation of AI is rapidly evolving as legislators and regulators are increasingly focused on these powerful emerging technologies and as they remain the object of intense geostrategic competition. The technologies underlying AI and its uses are subject to a variety of laws and regulations, including intellectual property, data privacy and cybersecurity, client protection, trade and export controls, competition, and equal opportunity laws, and are expected to be subject to increased regulation and new laws or new applications of existing laws and regulations. AI is the subject of ongoing review by various U.S. governmental and regulatory agencies, and various U.S. states are applying, or are considering applying, their platform moderation, data privacy and cybersecurity laws and regulations to AI or are considering general legal frameworks for AI. We may not be able to anticipate how to respond to these rapidly evolving frameworks, and we may need to expend resources to adjust our operations or offerings in certain jurisdictions if the legal frameworks are inconsistent across jurisdictions.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedRisk Factors
Strategic acquisitions to complement and further expand our business, which we refer to as partnerships, have been an important part of our competitive strategy. For example, on January 1, 2026, we completed the previously announced partnership with CAC Group, a nationally recognized specialty and middle-market insurance brokerage firm.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedRisk Factors
•failure to realize expected revenue synergies or other anticipated benefits from our partnerships, including the CAC Group Transaction, and the possibility that our experience operating such partnerships requires us to adjust our expectations regarding the impact of acquisitions on our operating results.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedRisk Factors
Similarly, our business enters into contractual agreements with referral partners and other trading partners. If we fail to maintain good relationships with our referral partners and other trading partners, referral partners and other trading partners may choose not to renew their contracts with us and develop their own insurance distribution channels, choose to work with another insurance broker and/or work directly with insurance carriers.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedRisk Factors
Should our dependence on a smaller number of insurance and reinsurance company partners, referral partners or other trading partners increase, whether as a result of the termination of insurance and reinsurance company partner, referral partner or other trading partner relationships, the consolidation of insurance and reinsurance company partner consolidation partners, referral partners or other trading partners, or otherwise, we may become more vulnerable to adverse changes in our relationships with our insurance and reinsurance company partners, these counterparties, particularly in states where we offer insurance products from a relatively small number of insurance and reinsurance company partners or partners, where a small number of insurance companies dominate the market. market, or where a significant portion of our commission and fees is directly or indirectly derived from our relationships with referral partners or other trading partners.
Read it in 10-K Feb 26, 2026 at sec.gov
Show the other 47
RewordedRisk Factors
There were no As of December 31, 2025, outstanding borrowings on the Revolving Facility, which has an expiration date of Facility were $107.0 million, bearing interest at 6.39% and maturing May 2029, however and we had unused letters of credit issued under the Revolving Facility of $12.0 $16.0 million.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedRisk Factors
Our business may be harmed if we lose our relationships with insurance and reinsurance company partners, referral partners or other trading partners, fail to maintain good relationships with insurance and reinsurance company partners, referral partners or other trading partners, become dependent upon a limited number of insurance and reinsurance company partners, referral partners or other trading partners or fail to develop new insurance and reinsurance company partner, referral partner or other trading partner relationships.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedRisk Factors
Goodwill is not amortized and is subject to assessment for impairment when the facts and circumstances suggest an impairment test is necessary, but in any event, at least annually.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedRisk Factors
Following the successful refinancing of our Term Loan B on January 10, 2025, 2, 2026, borrowings under our 2024 JPM Credit Agreement include $935.8 million $1.604 billion under the Term Loan B bearing interest of 7.30%, 6.25%, maturing May 2031.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedRisk Factors
Unfavorable ratings of Baldwin or our industry, as well as omission of inclusion of our stock into ESG-oriented investment funds may lead to negative investor sentiment and the diversion of investment to other companies or industries, which could have a negative impact on the price of our stock price. Class A common stock.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedRisk Factors
We may issue a substantial amount of our common stock in the future, which could cause dilution to investors and otherwise adversely affect the price of our stock price. Class A common stock.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedRisk Factors
As of December 31, 2024, 2025, our cash and cash equivalents were $148.1 $123.7 million and we had $588.0 $477.0 million of available borrowing capacity on the Revolving Facility under the 2024 JPM Credit Agreement.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedRisk Factors
Based on estimates of the partners’ future performance using financial projections for the earnout period, the aggregate estimated contingent earnout liabilities included on our consolidated balance sheet at December 31, 2024 2025 was $145.6 $23.3 million, of which $4.7 $9.2 million must be settled in cash and the remaining $140.8 $14.1 million can be settled in cash or stock at our option.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedRisk Factors
The undiscounted estimated contingent earnout obligation at December 31, 2024 2025 was $185.2 $26.6 million, of which $5.0 $9.2 million must be settled in cash and the remaining $180.2 $17.4 million can be settled in cash or stock at our option.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedMD&A
Effective January 1, 2026, the Company acquired the outstanding equity interests of the business of CAC Group for aggregate consideration paid by the Company at closing consisting of $438.0 million of cash (subject to customary purchase price adjustments) and 23,200,000 shares of the Company's Class A common stock. The purchase consideration also includes a deferred payment of $70.0 million in cash, payable upon the fourth anniversary of the closing date of the CAC Group Transaction. CAC Group may be entitled to receive up to $250.0 million of additional contingent consideration payable in cash based upon the achievement of certain post-closing revenue focused performance measures. The partnership with CAC Group will significantly expand the specialty capabilities of the Company's IAS operating group and strengthen its specialty product lines and data and analytics platform.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedMD&A
Colleague compensation and benefits expense increased $15.3 million, or 2%, year over year. Partnership activity contributed $8.2 million to the increase in colleague compensation and benefits in 2025, offset in part by a $1.4 million decrease related to our Wholesale Business, which was sold in the first quarter of 2024. After excluding colleague compensation and benefits expense related to our partnerships and divestitures, colleague compensation and benefits expense increased $8.5 million due to increases in colleague compensation of $33.8 million, inside advisor commissions of $8.9 million and benefits and other of $8.4 million as a result of the continued investment in our growth and elevated health plan costs, offset in part by a decrease in colleague earnout incentives of $43.7 million resulting from settlement activity in 2025.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedMD&A
Right-of-use assets and operating lease liabilities decreased $10.4 million and $10.1 million, respectively, due to ongoing measures to consolidate our facilities footprint in certain geographies.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedMD&A
Accrued expenses and other current liabilities increased $86.7 million as a result of increases in accrued expenses relating, in part, to the timing of expenses incurred in connection with January 2026 partnerships, deferred payments relating to 2025 partnerships, and accrued compensation and benefits relating to our overall growth and increased health insurance costs.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedMD&A
Long-term debt increased $172.2 million due to the 2025 Refinancings during which we upsized the Term Loans by $175.0 million in the aggregate to support growth in our business, including our 2025 partnerships.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedMD&A
Fiduciary assets and liabilities increased $78.5 million and $79.0 million, respectively, attributable to overall growth in our business and higher volumes of agency bill premium activity, as well as the timing of cash collections and carrier payable settlements.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedMD&A
(1) Transformation costs represent certain non-recurring colleague compensation and technology-related expenses related to our $3B/30 Catalyst Program, which is designed to accelerate the infusion of automation, business process optimization and artificial intelligence to transform and elevate our workforce and unlock new avenues for growth.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedMD&A
(1) Transformation costs represent certain non-recurring colleague compensation and technology-related expenses related to our $3B/30 Catalyst Program, which is designed to accelerate the infusion of automation, business process optimization and artificial intelligence to transform and elevate our workforce and unlock new avenues for growth.
Read it in 10-K Feb 26, 2026 at sec.gov
AddedMD&A
Colleague compensation and benefits expense for UCTS increased $15.0 million, or 15%, year over year. Partnership activity contributed $6.4 million to the increase in colleague compensation and benefits in 2025, offset in part by a $1.4 million decrease related to the divestiture of our Wholesale Business during 2024. After excluding colleague compensation and benefits expense related to partnership and divestiture activity, colleague compensation and benefits increased $10.0 million, or 10%, as a result of the continued investment in UCTS' growth and elevated health plan costs.
Read it in 10-K Feb 26, 2026 at sec.gov
RemovedMD&A
Investment income is earned by investing assets held in trust. Investment income increased $5.2 million year over year due to improvements in our cash management strategy and growing yield on our invested cash.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
Commissions, employee compensation and benefits expense increased $120.7 million, or 13%, year over year, primarily related to outside commissions, which increased $74.1 million, after excluding outside commissions related to the Wholesale Business between March and December of 2023 of $15.8 million, due to growth in UCTS and MIS. In addition, colleague earnout incentives, which relate to contingent earnout liabilities that were reclassified, at the partner's option, to an earnout incentive bonus payable to colleagues, increased $33.4 million. Other increases, after excluding amounts related to the Wholesale Business between March and December of 2023, were driven by continued investments in headcount to support the growth of existing and new products, including colleague compensation (fixed compensation plus share-based compensation) of $21.5 million, inside advisor commissions of $15.5 million, and benefits and other expense of $12.3 million. These increases were partially offset by commissions, employee compensation and benefits expense of $23.7 million incurred by our Wholesale Business between March and December of 2023, for which there were no comparable costs incurred in 2024, and a decrease in severance expense of $12.6 million relating primarily to the retirement of two of our executive officers at the end of 2023.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
Long term debt increased $428.0 million and our revolving line of credit decreased $341.0 million due to the May 2024 refinancing in which we upsized the term loan under a new $840 million senior secured first lien term loan facility and entered into a new senior secured first lien revolving facility with commitments in an aggregate principal amount of $600 million. Proceeds from the May 2024 refinancing were used to paydown our revolving line of credit.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
Effective January 1, 2024, our FounderShield Partner moved from UCTS to IAS. Prior year results of operations for IAS below have been recast to conform to the current organizational structure.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
Effective January 1, 2024, our FounderShield Partner moved from UCTS to IAS. Prior year results of operations for UCTS below have been recast to conform to the current organizational structure.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
Profit-sharing and other revenue decreased $12.2 million year over year, of which, $7.5 million is a function of strong profit-sharing revenue in 2023, which resulted from historically strong underwriting performance in that year. The remaining decrease relates to profit-sharing and other income earned by our Wholesale Business between March and December of 2023, for which there were no comparable revenues earned in 2024, and a reduction in other income.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
Commissions, employee compensation and benefits expense for UCTS includes both outside commissions paid to partners that distribute our MGA products and compensation paid primarily to colleagues. Commissions, employee compensation and benefits expense for UCTS increased $63.6 million year over year, primarily driven by outside commissions, which increased $66.8 million, or 35%, in line with the growth in UCTS core commissions and fees after excluding outside commissions relating to the Wholesale Business between March and December of 2023 of $15.8 million. Other increases, after excluding amounts relating to the Wholesale Business between March and December of 2023, included benefits and other expense of $7.0 million and colleague compensation of $8.9 million, which were driven by continued investments in headcount to support the growth of existing and new products, coupled with an increase in colleague compensation allocated to UCTS that was previously recognized in Corporate and Other. These increases were partially offset by compensation costs of $23.7 million incurred by our Wholesale Business between March and December of 2023, for which there were no comparable costs incurred in 2024.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
A substantial portion of the intercompany commissions revenue recorded during 2024 is related to the QBE Program Administrator Agreement. We expect intercompany commissions revenue to continue to grow as we serve as the MGA on more intersegment revenue such as homeowners insurance sold through MIS.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
Commissions, employee compensation and benefits expense in Corporate and Other decreased $58.0 million year over year, driven by a reduction in colleague compensation of $31.5 million, due in part to a decrease in corporate-related headcount, including the retirement of two of our executive officers at the end of 2023, coupled with a decrease in colleague compensation previously recognized in Corporate and Other that is now allocated to the operating groups. Other decreases included severance of $11.9 million relating to the retirement of two of our executive officers at the end of 2023 as mentioned above, and $11.5 million relating to an increase in intercompany commissions expense eliminations.
Read it in 10-K Feb 25, 2025 at sec.gov
RemovedMD&A
A significant portion of the year-over-year increase in intercompany commissions expense eliminated through Corporate and Other is related to the QBE Program Administrator Agreement. We expect intercompany commissions expense to continue to increase as we serve as the MGA on more intersegment revenue such as homeowners insurance sold through MIS.
Read it in 10-K Feb 25, 2025 at sec.gov
RewordedMD&A
For the Years Ended December 31, (in thousands, except per share data) 2025 2024 2023 Net loss attributable to Baldwin $ (33,813) $ (24,518) $ (90,141) Net loss attributable to noncontrolling interests (20,341) (16,563) (73,878) Amortization expense 121,316 102,730 92,704 Share-based compensation 71,113 65,503 56,222 Colleague earnout incentives 41,917 8,020 Gain on divestitures (38,953) Transaction-related partnership and integration expenses 23,051 10,501 Transformation costs(1) 7,003 — Severance 6,790 5,756 Depreciation 6,514 6,194 Loss on extinguishment and modification of debt 6,226 15,113 — Transaction-related partnership and integration expenses 10,501 20,728 Depreciation 6,194 5,698 Income tax expense 6,537 — Amortization of deferred financing costs 5,841 5,129 Severance 5,756 18,514 Change in fair value of contingent consideration 5,594 (4,949) 61,083 Other amortization/accretion, net 4,190 5,841 Income tax expense(2) 2,172 6,537 Colleague earnout incentives (1,779) 41,917 Impairment of right-of-use assets 1,275 — Gain on divestitures (290) (38,953) Loss on interest rate caps, net of cash settlements 18 2,544 12,588 Other(1) Other(3) 21,762 18,682 28,834 Adjusted pre-tax income 220,801 196,335 145,501 Adjusted income taxes(2) taxes(4) 21,859 19,437 14,405 Adjusted net income $ 198,942 $ 176,898 $ 131,096 Weighted-average shares of Class A common stock outstanding - diluted 67,939 63,455 60,135 Dilutive weighted-average shares of Class A common stock 3,229 3,598 3,874 Exchange of Class B common stock(3) stock(5) 47,737 50,896 53,132 Adjusted diluted weighted-average shares outstanding 118,905 117,949 117,141 Diluted loss per share $ (0.50) $ (0.39) $ (1.50) Effect of exchange of Class B common stock and net loss attributable to noncontrolling interests per share 0.04 0.10 0.04 Other adjustments to loss per share 2.31 2.01 2.64 Adjusted income taxes per share (0.18) (0.16) (0.12) Adjusted diluted EPS $ 1.67 $ 1.50 $ 1.12
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
Interest expense, net 122,778 123,644 119,465 Amortization expense 121,316 102,730 92,704 Share-based compensation 71,113 65,503 56,222 Colleague earnout incentives 41,917 8,020 Gain on divestitures (38,953) Transaction-related partnership and integration expenses 23,051 10,501 Transformation costs(1) 7,003 — Severance 6,790 5,756 Depreciation expense 6,514 6,194 Loss on extinguishment and modification of debt 6,226 15,113 — Transaction-related partnership and integration expenses 10,501 20,728 Income and other taxes(1) 7,184 1,285 Depreciation expense 6,194 5,698 Severance 5,756 18,514 Change in fair value of contingent consideration 5,594 (4,949) 61,083 Income and other taxes(2) 4,255 7,184 Colleague earnout incentives (1,779) 41,917 Impairment of right-of-use assets 1,275 — Gain on divestitures (290) (38,953) Loss on interest rate caps 18 244 1,670 Other(2) Other(3) 21,762 18,682 28,834 Adjusted EBITDA $ 341,472 $ 312,485 $ 250,204 Net loss margin (4) % (3) % (13) % Adjusted EBITDA margin 22.7 % 22.5 % 20.5 %
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
Net cash provided by used in investing activities increased $35.2 $153.6 million year over year, driven by net an increase in cash consideration paid for partnership activity of $85.7 million, a decrease in cash proceeds from divestitures divestitures, net of $57.0 cash transferred of $55.1 million, relating primarily to the sale of our Wholesale Business during 2024, offset and an increase in part by a decrease investments in cash relating and loans to higher capital expenditures business ventures, net of $19.7 repayments of $14.3 million due related to software development projects for infrastructure to support our business. investment in the Reciprocal in 2025.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
Net cash used in provided by financing activities increased $3.4 $182.8 million year over year, year driven by an increase in net proceeds from borrowings on our credit facilities of $99.4 $196.6 million primarily resulting from the May 2024 debt refinancing, offset 2025 Refinancings and borrowings on the Revolving Facility to fund partnerships and the payment of our earnout obligations during 2025, and a decrease in part by decreases in cash from additional payments of contingent earnout consideration classified as financing activity of $70.7 million, higher borrowing costs of $13.0 million, and fewer cash settlements from interest rate caps of $8.6 $32.5 million.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
Growth Total growth in our core commissions and fees of $71.4 million was driven by continued outperformance in our multi-family business MSI (accounting for $35.7 $41.2 million of the increase in core commissions and fees), momentum in our homeowners product the introduction of the Captive (accounting for $36.8 million of the increase in core commissions and fees) and commercial umbrella product (accounting for $9.9 $22.6 million of the increase in core commissions and fees), and growing contribution from building momentum in our reinsurance brokerage business Capacity Solutions group (accounting for $13.9 million of the increase in core commissions and commercial property program. fees).
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
For the Years Variance Ended December 31, (in thousands) 2025 2024 2023 Net cash provided by (used in) operating activities $ 102,151 (29,418) $ 44,644 51,453 $ 57,507 (80,871) Net cash provided by (used in) investing activities (140,276) 13,299 (21,922) 35,221 (153,575) Net cash used in provided by financing activities (29,644) (26,230) (3,414) 203,822 21,054 182,768 Net increase (decrease) in cash and cash equivalents and restricted fiduciary cash 34,128 85,806 (3,508) 89,314 (51,678) Cash and cash equivalents and restricted fiduciary cash at beginning of year period 312,769 226,963 230,471 (3,508) 85,806 Cash and cash equivalents and restricted fiduciary cash at end of year period $ 346,897 $ 312,769 $ 226,963 $ 85,806 34,128
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
This growth was offset in part by a decrease in commissions and fees of $28.8 $5.8 million derived from related to the divestiture of our Wholesale Business between March and December of 2023, for which there were no comparable revenues earned in 2024 as a result of the sale of the business in the first quarter of 2024.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
This growth was offset in part by a decrease in commissions and fees of $28.8 $5.8 million derived from related to the divestiture of our Wholesale Business between March and December of 2023, for which there were no comparable revenues earned in 2024 as a result of the sale of the business in the first quarter of 2024.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
We expect interest expense to remain relatively flat grow in the near term on a year-over-year basis due to an anticipated increase in higher borrowings from our revolving credit facility under the JPM Credit Facility to fund partnership opportunities and the settlement of contingent earnout liabilities, deferred payment obligations, offset slightly by a lower expected average interest rate. rates.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
We expect interest expense to remain relatively flat grow in the near term on a year-over-year basis due to an anticipated increase in higher borrowings from our revolving credit facility under the JPM Credit Facility to fund partnership opportunities and the settlement of contingent earnout liabilities, deferred payment obligations, offset slightly by lower expected average interest rates.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
We expect interest expense to remain relatively flat grow in the near term on a year-over-year basis due to an anticipated increase in higher borrowings from our revolving credit facility under the JPM Credit Facility to fund partnership opportunities and the settlement of contingent earnout liabilities, deferred payment obligations, offset slightly by lower expected average interest rates.
Read it in 10-K Feb 26, 2026 at sec.gov
RewordedMD&A
Total other income income, net for UCTS increased $33.2 IAS decreased $3.5 million year over year, driven by a $35.1 $3.8 million gain recorded on divestitures in connection with 2024 related to the sale of our Wholesale Business during the first quarter certain books of 2024. business.
Read it in 10-K Feb 26, 2026 at sec.gov

Sources

The two latest 10-Ks on EDGAR, section by section. Each change links to the text at sec.gov.

Also

New risk factors: paragraphs with nothing like them last year, quoted in full.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BWIN/export.csv") into a cell.

Next:Related parties
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.